Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
PaperCitations, authors & open-access status
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 14 citations, 2025 year and hybrid oa status.
14
Citations
2025
Year
hybrid
OA Status